Hinge Health, Inc. (HNGE)

Hinge Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Net Income	-528.26	-11.93	-108.14
Depreciation & Amortization	5.13	2.35	2.13
Other Amortization	46.67	33.51	23.84
Loss (Gain) From Sale of Investments	0.36	0.54	-10.76
Stock-Based Compensation	643.01	0.74	1.65
Provision & Write-off of Bad Debts	3.06	5.41	4.86
Other Operating Activities	3.49	4.88	13.11
Change in Accounts Receivable	-26.63	-1.34	-23.13
Change in Inventory	-4.76	0.61	10.57
Change in Accounts Payable	29.41	-10.98	11.56
Change in Unearned Revenue	83.22	77.16	35.97
Change in Other Net Operating Assets	-83.25	-51.95	-25.56
Operating Cash Flow	171.44	49	-63.91
Operating Cash Flow Growth	249.87%	-	-
Capital Expenditures	-0.71	-1.04	-1.98
Cash Acquisitions	-4	-	-
Sale (Purchase) of Intangibles	-5.36	-2.73	-2.64
Investment in Securities	-103.7	22.09	6.12
Investing Cash Flow	-113.76	18.31	1.5
Issuance of Common Stock	265.2	0.61	0.49
Repurchase of Common Stock	-360.26	-	-
Other Financing Activities	-55.42	-2.81	-3.49
Financing Cash Flow	-150.47	-2.2	-3
Net Cash Flow	-92.79	65.11	-65.41
Free Cash Flow	170.73	47.96	-65.89
Free Cash Flow Growth	255.97%	-	-
Free Cash Flow Margin	29.04%	12.29%	-22.51%
Free Cash Flow Per Share	3.13	3.54	-5.06
Levered Free Cash Flow	410.14	73.18	-
Unlevered Free Cash Flow	410.14	73.18	-
Change in Working Capital	-2.01	13.5	9.41

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q